Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment is closed for the study. The latest revision tag is v3.6.0, replacing v3.5.5.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page's revision tag has changed from v3.5.4 to v3.5.5, signaling a new version of the record display. This likely reflects minor updates or fixes to the page's metadata or UI without changing the underlying study data.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a new release of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check63 days agoChange DetectedThe ClinicalTrials.gov page footer/version indicator has been updated from “v3.5.2” to “v3.5.3,” reflecting a software release rather than a change to the study history details.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision updated to v3.5.0 (replacing v3.4.3) in the record history.SummaryDifference0.0%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.